March 23, 2007 – Biotech took a double hit today when both of its two biggest companies traded lower by more than 4%. Amgen was off on very disappointing news about a Vectibix drug trial, and Genentech, with one week left in the quarter, warned the investment community to expect flat revenues for its first quarter. More details...
